Alzheimer's disease prevention: Apolipoprotein e4 moderates the effect of physical activity on brain beta-amyloid deposition in healthy older adults

J Sci Med Sport. 2024 Jun;27(6):402-407. doi: 10.1016/j.jsams.2024.03.012. Epub 2024 Apr 3.

Abstract

Objectives: To investigate if higher baseline physical activity levels are associated with less β-amyloid burden and whether the ApoE4 genotype moderates this association cross-sectionally and longitudinally.

Design: Prospective cohort study.

Methods: 204 cognitively normal older adults (74.5 ± 6.6 years; 26 % ApoE4-carrier) were analyzed. Baseline physical activity was measured using the Minnesota Physical Activity Questionnaire. Brain β-amyloid burden was measured with positron emission tomography using 11C-labeled Pittsburgh compound. A subsample of 128 participants underwent longitudinal positron emission tomography (2.0 ± 0.9 scans over 5 ± 3 years). Statistical analysis was run according to physical activity (high/low group) and the ApoE4 genotype (carrier/noncarrier).

Results: The ApoE4 genotype moderated the relationship between physical activity and β-amyloid, such that low physical activity had a greater impact on β-amyloid deposition in ApoE4-carriers than noncarriers. This ApoE4 × physical activity effect on brain β-amyloid deposition was also observed when all available β-amyloid scan timepoints were included in the model. β-amyloid deposition increased over time (p < 0.001), and ApoE4-carriers had disproportionately greater β-amyloid accumulation than ApoE4-noncarriers. The lower physical activity group had marginally greater β-amyloid accumulation than the higher physical activity group (p = 0.099), but there was no significant ApoE4 effect on β-amyloid accumulation.

Conclusions: Low physical activity in combination with the ApoE4-carrier genotype is associated with increased β-amyloid burden, suggesting that ApoE4 moderates the effect of physical activity on β-amyloid load. However, this effect was insufficient for baseline physical activity to modulate the change in β-amyloid accumulation over time.

Keywords: Age; Amyloid beta; Dementia; Exercise; Genetics; PET.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / prevention & control
  • Amyloid beta-Peptides* / metabolism
  • Apolipoprotein E4* / genetics
  • Brain* / diagnostic imaging
  • Brain* / metabolism
  • Cross-Sectional Studies
  • Exercise* / physiology
  • Female
  • Genotype
  • Humans
  • Longitudinal Studies
  • Male
  • Positron-Emission Tomography*
  • Prospective Studies

Substances

  • Amyloid beta-Peptides
  • Apolipoprotein E4
  • ApoE protein, human